Journal of Clinical Endocrinology & Metabolism, Vol 78, 1497-1504, Copyright © 1994 by Endocrine Society

ARTICLES

Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas

KE Friend, YK Chiou, MB Lopes, ER Laws Jr, KM Hughes and MA Shupnik
Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908.

Forty-one human pituitary adenoma specimens were examined for the presence of estrogen receptor (ER) messenger ribonucleic acid and protein using a combination of ribonuclease protection assay, [3H] estradiol ([3H]E2) binding, and ER immunohistochemistry. ER messenger ribonucleic acid prevalence was high in PRL-immunoreactive tumors (2 of 2), moderate in GH/PRL tumors (2 of 5), and low or absent (0 of 4) in GH tumors. In the GH/PRL-immunostaining tumors, the presence of the ER was uniformly associated with elevated serum PRL levels. Among the gonadotropin-immunostaining tumors, 10 of 17 were ER positive; within this group, those with gonadotroph adenoma characteristics were ER positive, whereas those with null cell/oncocytic characteristics were ER negative. Of the tumors that did not immunostain for any known anterior pituitary hormones, 3 of 11 were ER positive. ER immunohistochemistry in 14 tumors revealed a 100% correlation with ribonuclease protection assay results, whereas [3H]E2 binding, determined in 9 tumors, showed an 87% correlation. In summary, it appears that PRL and a specific class of gonadotropin-immunostaining tumors (identifiable by specific characteristics on electron microscope) contain ER, whereas GH-immunostaining tumors are ER negative. ER expression in normal pituitary paralleled that in macroadenomas (GH, 2.3%; PRL, 50%; FSH, 70%; LH, 83%; TSH, 4%; ACTH, 1%). The ER-positive tumors represent a subset whose growth and secretory profiles may be influenced by the gonadal steroidal milieu or by pharmacological agents that affect E2 levels or ER function.

This article has been cited by other articles:

				M. Cosma, J. Bailey, J. M. Miles, C. Y. Bowers, and J. D. Veldhuis Pituitary and/or Peripheral Estrogen-Receptor {alpha} Regulates Follicle-Stimulating Hormone Secretion, Whereas Central Estrogenic Pathways Direct Growth Hormone and Prolactin Secretion in Postmenopausal Women J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 951 - 958. [Abstract] [Full Text] [PDF]

				N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee What Can We Learn from Rodents about Prolactin in Humans? Endocr. Rev., February 1, 2008; 29(1): 1 - 41. [Abstract] [Full Text] [PDF]

				T. Kitahashi, S. Ogawa, T. Soga, Y. Sakuma, and I. Parhar Sexual Maturation Modulates Expression of Nuclear Receptor Types in Laser-Captured Single Cells of the Cichlid (Oreochromis niloticus) Pituitary Endocrinology, December 1, 2007; 148(12): 5822 - 5830. [Abstract] [Full Text] [PDF]

				N Y Y Al-Brahim and S L Asa My approach to pathology of the pituitary gland J. Clin. Pathol., December 1, 2006; 59(12): 1245 - 1253. [Abstract] [Full Text] [PDF]

				D. Giacomini, M. Paez-Pereda, M. Theodoropoulou, M. Labeur, D. Refojo, J. Gerez, A. Chervin, S. Berner, M. Losa, M. Buchfelder, et al. Bone Morphogenetic Protein-4 Inhibits Corticotroph Tumor Cells: Involvement in the Retinoic Acid Inhibitory Action Endocrinology, January 1, 2006; 147(1): 247 - 256. [Abstract] [Full Text] [PDF]

				A.L. Filby and C.R. Tyler Molecular Characterization of Estrogen Receptors 1, 2a, and 2b and Their Tissue and Ontogenic Expression Profiles in Fathead Minnow (Pimephales promelas) Biol Reprod, October 1, 2005; 73(4): 648 - 662. [Abstract] [Full Text] [PDF]

				J. S. Jorgensen, C. C. Quirk, and J. H. Nilson Multiple and Overlapping Combinatorial Codes Orchestrate Hormonal Responsiveness and Dictate Cell-Specific Expression of the Genes Encoding Luteinizing Hormone Endocr. Rev., August 1, 2004; 25(4): 521 - 542. [Abstract] [Full Text] [PDF]

				J. E. B. Cavaco, C. R.A. Santos, P. M. Ingleton, A. V.M. Canario, and D. M. Power Quantification of Prolactin (PRL) and PRL Receptor Messenger RNA in Gilthead Seabream (Sparus aurata) after Treatment with Estradiol-17{beta} Biol Reprod, February 1, 2003; 68(2): 588 - 594. [Abstract] [Full Text] [PDF]

				D. B. Speert, S. J. MCClennen, and A. F. Seasholtz Sexually Dimorphic Expression of Corticotropin-Releasing Hormone-Binding Protein in the Mouse Pituitary Endocrinology, December 1, 2002; 143(12): 4730 - 4741. [Abstract] [Full Text] [PDF]

				D. A. Schreihofer, D. F. Rowe, E. F. Rissman, E. M. Scordalakes, J.-a. Gustafsson, and M. A. Shupnik Estrogen Receptor-{alpha} (ER{alpha}), But Not ER{beta}, Modulates Estrogen Stimulation of the ER{alpha}-Truncated Variant, TERP-1 Endocrinology, November 1, 2002; 143(11): 4196 - 4202. [Abstract] [Full Text] [PDF]

				D. A. Schreihofer, M. H. Stoler, and M. A. Shupnik Differential Expression and Regulation of Estrogen Receptors (ERs) in Rat Pituitary and Cell Lines: Estrogen Decreases ER{alpha} Protein and Estrogen Responsiveness Endocrinology, June 1, 2000; 141(6): 2174 - 2184. [Abstract] [Full Text] [PDF]

				E. Nishihara, Y. Nagayama, S. Inoue, H. Hiroi, M. Muramatsu, S. Yamashita, and T. Koji Ontogenetic Changes in the Expression of Estrogen Receptor {alpha} and {beta} in Rat Pituitary Gland Detected by Immunohistochemistry Endocrinology, February 1, 2000; 141(2): 615 - 620. [Abstract] [Full Text] [PDF]

				V. L. Green, V. Speirs, A. M. Landolt, P. M. Foy, and S. L. Atkin 17{beta}-Hydroxysteroid Dehydrogenase Type 1, 2, 3, and 4 Expression and Enzyme Activity in Human Anterior Pituitary Adenomas J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1340 - 1345. [Abstract] [Full Text]

				D. A. Schreihofer, E. M. Resnick, A. Y. Soh, and M. A. Shupnik Transcriptional Regulation by a Naturally Occurring Truncated Rat Estrogen Receptor (ER), Truncated ER Product-1 (TERP-1) Mol. Endocrinol., February 1, 1999; 13(2): 320 - 329. [Abstract] [Full Text]

				S. L. Asa and S. Ezzat The Cytogenesis and Pathogenesis of Pituitary Adenomas Endocr. Rev., December 1, 1998; 19(6): 798 - 827. [Abstract] [Full Text]

				M. A. Shupnik, L. K. Pitt, A. Y. Soh, A. Anderson, M. B. Lopes, and E. R. Laws Jr. Selective Expression of Estrogen Receptor {alpha} and {beta} Isoforms in Human Pituitary Tumors J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3965 - 3972. [Abstract] [Full Text]

				S. S. Chaidarun, B. Swearingen, and J. M. Alexander Differential Expression of Estrogen Receptor-{beta} (ER{beta}) in Human Pituitary Tumors: Functional Interactions with ER{alpha} and a Tumor-Specific Splice Variant J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3308 - 3315. [Abstract] [Full Text]

				S. Misiti, L. Schomburg, P. M. Yen, and W. W. Chin Expression and Hormonal Regulation of Coactivator and Corepressor Genes Endocrinology, May 1, 1998; 139(5): 2493 - 2500. [Abstract] [Full Text] [PDF]

				I. Treilleux, N. Peloux, M. Brown, and A. Sergeant Human Estrogen Receptor (ER) Gene Promoter-P1: Estradiol-Independent Activity and Estradiol Inducibility in ER+ and ER- Cells Mol. Endocrinol., August 1, 1997; 11(9): 1319 - 1331. [Abstract] [Full Text]

				K. M. Scully, A. S. Gleiberman, J. Lindzey, D. B. Lubahn, K. S. Korach, and M. G. Rosenfeld Role of Estrogen Receptor-{{alpha}} in the Anterior Pituitary Gland Mol. Endocrinol., June 1, 1997; 11(6): 674 - 681. [Abstract] [Full Text]

				N. J. L. Gittoes, C. J. McCabe, J. Verhaeg, M. C. Sheppard, and J. A. Franklyn Thyroid Hormone and Estrogen Receptor Expression in Normal Pituitary and Nonfunctioning Tumors of the Anterior Pituitary J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1960 - 1967. [Abstract] [Full Text] [PDF]

				S. S. Chaidarun, A. Klibanski, and J. M. Alexander Tumor-Specific Expression of Alternatively Spliced Estrogen Receptor Messenger Ribonucleic Acid Variants in Human Pituitary Adenomas J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1058 - 1065. [Abstract] [Full Text] [PDF]